Copyright: ©Author(s) 2026.
World J Transl Med. Nov 28, 2026; 12(4): 127008
Published online Nov 28, 2026. doi: 10.5528/wjtm.127008
Published online Nov 28, 2026. doi: 10.5528/wjtm.127008
Table 1 Preclinical studies (experimental and on healthy humans) demonstrated the value of Salvia species or their active ingredients on the behavior-like psychiatric illness
| Salvia spp., or active ingredients | Experimental model | Psychiatric pathological conditions | Results | Ref. |
| Asiatic acid (a triterpene) | Quinolinic acid toxicity-induced induced spatial memory defect in rats | Memory | Improved | [14] |
| Hugan Tiaoshen formula | PPI network identified core targets by topological analysis | Schizophrenia | Strong binding between, β-sitosterol, and the targets | [20] |
| Machine learning | Sleep disorder | |||
| Tanshinone IIA | Conditioned fear and single-prolonged stress tests in mouse | Posttraumatic stress disorder | Decreased freezing time in contextual fear test | [33] |
| Relieved anxiety-like behavior in open field and elevated plus maze tests | ||||
| Upregulated synaptic plasticity-related proteins | ||||
| Tanshinone IIA | Depression-like behavior | Depression-like behavior | Upregulated expression of GABA transporter 1 | [34] |
| Cognitive impairment model (in rat) | Cognitive impairment | Reduced expression of synaptic proteins centrally | ||
| Tashinone I and II | Targeting recombinant human monoamine oxidase isoenzymes | Depression | Inhibition of monoamine oxidase A | [35] |
| Parkinson | ||||
| Mesyl Sal B (analogue of Salvinorin A) | Cocaine-induced hyperactivity and behavioral sensitization in rats | Drug dependence | Attenuate with limited antinociceptive effect | [52] |
| Essential oil of Salvia fruticose | H2O2-induced astrocyte cell death, in vitro study | Neurodegenerative disease | Protects the cell from death | [59] |
| α-humulene | In vivo behavioral responses of adult zebrafish | Behavior responses | Anxiolytic-like effect | [61] |
| Salvia guaranitica extracts | In vivo sedative and hypnotic effects in mice | Sedative and hypnosis | Cirsiliol produced a dose-dependent hypnotic action | [62] |
| Active ingredients | ||||
| Salvia hispanica L. seeds | In vivo writhing test in rats | Analgesia | Antinoceptive | [71] |
| Salvia officinalis aqueous extract Salvia lavandulaefolia-encapsulated essential oil | In vivo long-term administration in rats | Neuronal plasticity (neurogenesis, neuronal activity, neurotrophins) | Improved | [72] |
| Y-maze markers | ||||
| Morris water maze markers | ||||
| Essential oil extract of Salvia lavandulaefolia | Controlled-placebo study on healthy human subjects | Cognitive function | Improved immediate word recall | [73] |
| Cognitive Drug Research Computerized test Batter | ||||
| Salvia lavandulaefolia essential oil | Double-blind controlled-placebo study on healthy human subjects | Cognitive function | Improved performance of secondary memory | [74] |
| Cognitive Demand Battery | Improved attention tasks | |||
| Computerized memory and attention tasks | Reduced mental fatigue | |||
| Salvia lavandulaefolia eessential oil | In vivo, experimental rats | Choline esterase activity in the brain | A significant decrease of choline esterase in striatum and hippocampus | [75] |
| Salvia lavandulaefolia Vahl. essential oil | In vitro, human red cell | Choline esterase activity in red cell | Significant decrease | [78] |
| A combination of Salvia officinalis and Salvia lavandulaefolia | Cross-over, randomized, double-bind placebo-controlled trial; healthy subjects. A Stroop task | Cognitive function | Improved the cognitive functions (perceived exertion, working memory, and reaction time) | [78] |
| A simple reaction time task | ||||
| A backward digit span memory task | ||||
| Salvia leucantha Cav. essential oil | In vitro | Choline esterase activity | Significant inhibition | [81] |
| Salvia limbata C.A. Mey extract | Sedative-hypnotic-anxiolytic (pentobarbital-model inducing loss of righting reflex test and open field test) | Anxiety | Anxiolytic and hypnotics (modulates GABA-A receptors) | [85] |
| Insomnia | ||||
| Rosmarinic acid | In vitro, GABA receptors, glutamate release in cerebrocortical synaptosomes | CNS-neurotransmitters and receptors | Activates GABA-A receptors | [86] |
| Inhibits glutamate release | ||||
| Decreases Ca2+ influx | ||||
| S. limbate and and S. hypolecuca extracts | In vivo, morphine-dependence model in mice | Antinociceptive activity | Significant inhibition of pain and development of morphine dependence | [87] |
| Salvia cinnabarina, Salvia lavanduloides, Salvia longispicata methanolic extracts | In vivo evaluation of the antinociceptive effect and acute oral toxicity | Antinociceptive | A significant antinociceptive effect at a dose of 300 mg/kg administered orally LD50 > 2000 mg/kg | [88] |
| Salvia officinalis, Salvia microphylla extracts | Scopolamine-induced memory impairment in rats. Histopathology | Cognitive function | Reduced β-amyloid deposition | [90] |
| Virtual docking to the active sites of the human acetylcholinesterase | Decreased acetylcholine esterase activity | |||
| Salvia miltiorrhizae radix extract | Estimation of glycogen synthase kinase 3β, AutoDockTools | Cognitive function | Decrease the glycogen synthase kinase 3β | [91] |
| Rosmarinic acid | Chronic cortisone injection induced depression-like behavior in mice | Behavior like-depression | Modulating the hippocampal glucocorticoid signaling and hippocampal neurogenesis | [93] |
| Rosmarinic acid | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine MPTP-induced mouse model of Parkinson’s disease | Motor activity | Decreased the mRNA levels of α-synuclein | [94] |
| Salvia miltiorrhiza Bunge ethanolic extract | Anxiolytic model using plus-maze test and the hole-board test | A decrease in spontaneous locomotor activity | Anxiolytic effect via activation of the benzodiazepine and serotonin (5HT1A) receptors | [97] |
| Salvia miltiorrhiza: Tanshinone IIA | Double stress exposure in mice | PTSD-like symptoms | Increased the spine density and upregulated synaptic plasticity-related proteins | [99] |
| Salvianolic Acid B: Salvia miltiorrhiza | Pain-depression comorbidity models | Alzheimer’s disease models | Suppresses amyloid-beta formation and neuroinflammation | [101] |
| Histopathological | ||||
| Signaling pathways | ||||
| Salvianolic acid A | Integrative network pharmacology, molecular docking, and pathway enrichment analysis | Cognitive function | Ameliorates cognitive decline Decreases tau protein hyperphosphorylation | [105] |
| Reduced amyloid-β accumulation | ||||
| Compound Danshen | Alzheimer’s disease rat model: Aβ25-35 peptide intracerebroventricularly injection | Memory | Improvement | [106] |
| Spatial learning and memory impairments | ||||
| Memory impairment in both Morris water maze and passive avoidance task | ||||
| Salvianolic acids | Chronic mild stress-induced depressive-like behaviors in rats. Sucrose preference | Behavior-like depression | Weight gains | [109] |
| Alleviated depressive-like behaviors | ||||
| Immobility duration in forced swimming | Reduced cerebral TLR4/MyD88 mRNA levels in brain | |||
| Danshen-Honghua | In vivo, chronic mild stress in rats | Menopausal depression | Improved open-field locomotor scores | [110] |
| Improved sucrose intake | ||||
| Improved serum monoamines level | ||||
| Tanshinone IIA of Salvia miltiorrhiza | Brain-derived neurotrophic factor expression in the hippocampus of depressive mice: In ex-vivo and in vitro | Cognitive function | Improved p-ERK and p-CREB, BDNF proteins expression in mice | [111] |
| Salvianolic acid B of Salvia militiorrhiza Bunge | Chronic mild stress for 6 weeks, in rats | Behavior-like depression | Improved sucrose consumption | [112] |
| Reverse the hyperactivity of hypothalamic-pituitary-adrenal | ||||
| Decreased inflammatory cytokines | ||||
| Tanshinone IIA | Acrylamide-induced depression and cognitive impairment in adult zebrafish model; in vivo, and ex vivo | Cognitive function | Restored the morphological brain damage | [114] |
| Motor activity | ||||
| Saebias A-G (1-7) from Salvia plebeia R.Br. | In vitro neuroprotection using; lipopolysaccharide induced changes in BV-2 cells, and H2O2 in PC12 cells | Neuroinflammation | Neuroprotection | [128] |
| Salvia rosmarinus essential oil | In vitro assay of AChE and BuChE | Neuroprotection | Inhibition | [134] |
| Rosmarinus officinalis | Docking analysis of ursolic acid, rosmarinic acid and carnosic acid, targeting Alzheimer’s disease-associated proteins | Alzheimer’s diseases | Strong binding affinity with acetylcholine esterase, butylcholine esterase-1 and synapsin I, II and III | [135] |
| Rosmarinus officinalis extract | Stress markers | Anxiety, depression | Ameliorates stress markers | [140] |
| In vivo stress model using tail suspension test and elevated plus maze test in mice | Reversed the behavioral changes | |||
| Improved oxytocin expression | ||||
| Rosemary oils | Scopolamine-induced amnesia-like Alzheimer’s dementia | Cognitive function | Improved performance of working and spatial memory | [142] |
| Rosmarinus officinalis | AlCl3-induced mouse model of AD, formation of amyloid beta plaques in hippocampus | Cognitive function | Improved the memory | [143] |
| Rosemary oils | Docking analysis targeting ACE, BACE1, GSK3, and TACE proteins (AD progression) | Alzheimer’s dementia | Highest binding affinity against each protein | [144] |
| Rosmarinus officinalis L. | Network pharmacology | Insomnia | Upregulation of GABA-A expression | [146] |
| Open-field experiments | ||||
| ELISA kits (5-HT, GABA, and DA), western-blotting, Rt-PCR and immunohistochemical assay experiments |
- Citation: Al-Nimer M, Ibraheem F. Neuropsychiatric effects and safety of Salvia species: A critical narrative review of preclinical and clinical evidence. World J Transl Med 2026; 12(4): 127008
- URL: https://www.wjgnet.com/2220-6132/full/v12/i4/127008.htm
- DOI: https://dx.doi.org/10.5528/wjtm.127008